Table 3.
Bone Metabolism Indices According to T2DM and Treatment Status
| Metabolic Indexesa | Control Group | ORL Group | CGI Group | Combined DM Group |
|---|---|---|---|---|
| n=30 | n=25 | n=25 | n=50 | |
| Serum Cre (μmol/L) | 62.27±10.83 | 51.92±10.64 | 59.52±16.07 | 55.72±14.02 |
| Serum Ca (mmol/L) | 2.27±0.17 | 1.98±0.20 | 2.19±0.11* | 2.02±0.22# |
| Serum P (mmol/L) | 1.20±0.15 | 1.58±0.43 | 1.28±0.20* | 1.43±0.37# |
| PTH (pg/mL) | 31.52±8.96 | 26.64±8.46 | 21.75±10.4 | 24.19±9.71# |
| CT (ng/mL) | – | 0.49±1.30 | 0.73±1.44 | 0.61±1.32 |
Notes: aValues are mean ± SD unless specified. *P <0.05 vs the ORL group; #P <0.05 vs the control group.
Abbreviations: ORL, oral glucose-lowering medication; CGI, oral glucose-lowering medication in combination with insulin glargine injection; DM, diabetes mellitus; serum Cre, serum creatinine; Serum Ca, serum calcium; Serum P, serum phosphate; PTH, parathyroid hormone; CT, calcitonin.